Skip to main content
. 2020 May 2;25(9):2132. doi: 10.3390/molecules25092132

Table 5.

Bioaccessibility of total phenolic content evaluated by the Folin-Ciocalteu method in non-digested samples and during the simulated in vitro digestion.

Samples TPC in CS1 TPC in CS2 TPC in CS3 TPC in CS4
mg GAE/g ± SD % mg GAE/g ± SD % mg GAE/g ± SD % mg GAE/g ± SD %
Not digested 5.7 ± 0.1 5.8 ± 0.2 6.5 ± 0.2 6.9 ± 0.3
Digestion Stage
OS 7.4 ± 0.3 28.2 7.3 ± 0.3 24.7 8.5 ± 0.3 33.0 8.3 ± 0.3 20.9
GS 7.6 ± 0.3 32.0 7.8 ± 0.4 34.5 10.1 ± 0.5 59.1 9.4 ± 0.6 37.0
DS 8.4 ± 0.4 46.7 8.7 ± 0.4 48.8 10.3 ± 0.4 62.2 10.1 ± 0.2 47.2
PS 8.1 ± 0.5 40.9 8.3 ± 0.5 42.7 9.7 ± 0.3 52.7 10.4 ± 0.4 51.5
VS 6.2 ± 0.5 8.0 6.9 ± 0.6 18.6 7.4 ± 0.4 16.2 8.1 ± 0.3 18.0
Total colon stage 14.3 ± 0.5 148.9 15.2 ± 0.6 161.3 17.1 ± 0.4 168.9 18.5 ± 0.4 169.5

OS: oral stage; GS: gastric stage; DS: duodenal stage; PS: Pronase E stage; VS: Viscozyme stage; GAE: gallic acid equivalents; TPC: total phenolic content; %: percentage of increase or decrease in TPC (not digested vs. digested stage). The differences between average values were evaluated by using Tukey’s test at the level of significance p < 0.05.